News

US FDA extends review of KalVista's swelling disorder drug due to heavy workload
The U.S. Food and Drug Administration extended the review of KalVista Pharmaceuticals' drug for a type of hereditary swelling ...
Pharmaceutical Technology13h
Bharat Biotech acquires licence for GSK’s Shigella vaccine development
GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for the continued development and ...
Healio14h
Disease burden in eosinophilic granulomatosis polyangiitis improves with mepolizumab
Patients with eosinophilic granulomatosis with polyangiitis experienced significant improvements in a variety of outcomes ...